Cargando…
New Developments and Challenges in Antibody-Based Therapies for the Respiratory Syncytial Virus
Since the discovery of the human respiratory syncytial virus (hRSV), multiple research efforts have been conducted to develop vaccines and treatments capable of reducing the risk of severe disease, hospitalization, long-term sequelae, and death from this pathogen in susceptible populations. In this...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094422/ https://www.ncbi.nlm.nih.gov/pubmed/37063935 http://dx.doi.org/10.2147/IDR.S379660 |